Lipocine Inc.LPCNNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank21
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P21
Within normal range
vs 2Y Ago
-0.8x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025-521.61%-5143.7%
2024-9.95%-101.6%
2023627.97%+129.3%
2022-2144.28%-80291.0%
2021-2.67%-
20200.00%+100.0%
2019-7409.51%-180.5%
2018-2641.68%-
20170.00%-
20160.00%-